Dejan Micic to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Dejan Micic has written about Antineoplastic Agents, Immunological.
Connection Strength
0.130
-
Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 Therapies. Clin Pharmacol Ther. 2018 02; 103(2):318-331.
Score: 0.130